SEARCH

SEARCH BY CITATION

References

  • AKESSON, C., SWANSON, C. & PATIL, P.N. (1983). Muscarinic receptors of rabbit irises. Naunyn-Schmiedeberg's Arch. Pharmacol., 322, 104110.
  • ARAVIND MENON, I., WAKEHAM, D.C., PERSAD, S.D., AVARIA, M., TROPE, G.E. & BASU, P.K. (1992). Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J. Ocular Pharmacol., 8, 3542.
  • BOGNAR, I.T., ALTES, U., BEINHAUER, C., KESSLER, I. & FUDER, H. (1992). A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 611618.
  • CHOPPIN, A. & EGLEN, R.M. (2000). Pharmacological characterisation of muscarinic receptors in feline and human isolated ciliary smooth muscle. Br. J. Pharmacol., 129, 206P.
  • CHOPPIN, A., EGLEN, R.M. & HEGDE, S.S. (1998). Pharmacological characterisation of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle. Br. J. Pharmacol., 124, 883888.
  • CHOPPIN, A., HEGDE, S.S. & EGLEN, R.M. (1999a). Pharmacological characterisation of muscarinic receptors in dog ciliary smooth muscle. Br. J. Pharmacol., 126, 93P.
  • CHOPPIN, A., LOURY, D.N., WATSON, N., HEGDE, S.S. & EGLEN, R.M. (1999b). S-secoverine: a defining ligand in muscarinic M5 receptors characterization. Br. J. Pharmacol., 128, 33P.
  • CHOPPIN, A., SMITH, S., HEGDE, S.S. & EGLEN, R.M. (1999c). Role of pigmentation in the atypical behaviour of darifenacin in dog ciliary smooth muscle. Br. J. Pharmacol., 128, 90P.
  • DIXON, W.J. & MASSEY, F.J. (1983). Introduction to statistical analysis, 4th edition, New York: McGraw-Hill Publishing Company.
  • DOODS, H., ENTZEROTH, M. & MAYER, N. (1991). Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug. Eur. J. Pharmacol., 192, 147152.
  • DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E. & BRANN, M.R. (1991). Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256, 727733.
  • EGLEN, R.M., BONHAUS, D.W., CALIXTO, J.J., CHOPPIN, A., LEUNG, E., LOEB, M., LOURY, D., MOY, T., WILDA, M. & HEGDE, S.S. (1997). Characterization of the interaction of tolterodine at muscarinic receptor subtypes in vitro and in vivo. Br. J. Pharmacol., 120, 63P.
  • EGLEN, R.M., HEGDE, S.S. & WATSON, N. (1996). Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev., 48, 531565.
  • EGLEN, R.M. & NAHORSKI, S.R. (2000). The muscarinic M5 receptor: a silent or emerging subtype Br. J. Pharmacol., 130, 1321.
  • FERRARI-DILEO, G. & FLYNN, D.D. (1995). Characterization of muscarinic receptors on cultured microglial cells. Life Sci., 56, 1037 (abstract).
  • FUDER, H., SCHÖPF, J., UNCKELL, J., WESNER, M.TH., MELCHIORRE, C., TACKE, R., MUTSCHLER, E. & LAMBRECHT, G. (1989). Different muscarinic receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 611618.
  • FURCHGOTT, R.F. (1972). The classificiation of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Catecholamines, Handbook of Experimental Pharmacology, Vol. 33. Ed. Blaschko, H. & Muscholl, E. pp. 283335. Berlin, Heidelberg, New York: Springer.
  • GERMAN, E.J., WOOD, D. & HURST, M.A. (1998). Comparison of muscarinic receptor subtypes in the sheep ciliary muscle and iris sphincter using a radioligand binding aproach. Br. J. Pharmacol., 125, 62P.
  • GERMAN, E.J., WOOD, D. & HURST, M.A. (1999). Ocular effects of antimuscarinic compounds: is clinical effect determined by binding affinity for muscarinic receptors or melanin pigment J. Ocular Pharmacol. Ther., 15, 257269.
  • GIL, D.W., KRAUSS, H.A., BOGARDUS, A.M. & WOLDEMUSSIE, E. (1997). Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest. Ophthalmol. Vis. Sci., 38, 14341442.
  • HEGDE, S.S., CHOPPIN, A., BONHAUS, D., BRIAUD, S., LOEB, M., MOY, T.M., LOURY, D. & EGLEN, R.M. (1997). Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br. J. Pharmacol., 120, 14091418.
  • HONKANEN, R.E., HOWARD, E.F. & ABDEL-LATIF, A.A. (1990). M3-muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary processees. Invest. Ophthalmol. Vis. Sci., 31, 590593.
  • ITO, S. (1986). Re-examination of the structure of eumelanin. Biochim. Biophys. Acta, 883, 155161.
  • LONGHURST, P.A., LEGGETT, R.E. & BRISCOE, J.A.K. (1995). Characterization of functional muscarinic receptors in the rat urinary bladder. Br. J. Pharmacol., 116, 22792285.
  • LOURY, D.N., HEGDE, S.S., BONHAUS, D.W. & EGLEN, R.M. (1999). Ionic strength of assay buffers influences antagonist binding affinity estimates at muscarinic M1-M5 cholinoceptors. Life Sci., 64, 6P.
  • LUNA, L.G. (1968). Manual of histologic staining methods of the Armed Forces Institute of Pathology, 3rd edition New York: McGraw-Hill Book Company.
  • MCINTYRE, P. & QUINN, P. (1995). Characterisation and comparison of muscarinic receptors in the dog ciliary muscle with ileum. Br. J. Pharmacol., 115, 139P.
  • NEWGREEN, D.T. & NAYLOR, A.M. (1996). Characterization of functional muscarinic receptors in human bladder. Br. J. Pharmacol., 119, 45P.
  • NILVEBRANT, L., SUNDQUIST, S. & GILLBERG, P.-G. (1996). Tolterodine is not subtype (m1-m5) selective but exhibits functional bladder selectivity in vivo. Neurourol. Urodyn., 15, 34 (abstract).
  • PARKER, R.B. & WAUD, D.R. (1971). Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther., 177, 112.
  • SALAZAR, M., SHIMADA, K. & PATIL, P.N. (1976). Iris pigmentation and atropine mydriasis. J. Pharmacol. Exp. Ther., 197, 7988.
  • SMITH, C.M. & WALLIS, R.M. (1997). Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors. J. Receptor Signal transduction Res., 17, 177184.
  • TOBIN, G. (1995). Muscarinic receptor subtypes in the submandibular gland and the urinary bladder of the rabbit: in vivo and in vitro functional comparisons of receptor antagonists. J. Auton. Pharmacol., 15, 451463.
  • TOBIN, G. & SJOGREN, C. (1995). In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]-acetylcholine in the rabbit urinary bladder. Eur. J. Pharmacol., 281, 18.
  • WALLIS, R.M. (1995). Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists. Life Sci., 56, 861868.
  • WOLDEMUSSIE, E., FELDMANN, B.J. & CHEN, J. (1993). Sphincter and ciliary smooth muscle cells. Exp. Eye Res., 56, 385392.
  • ZHANG, X., HERNANDEZ, M.R., YANG, H. & ERICKSON, K. (1995). Expression of muscarinic receptor subtype mRNa in the human ciliary muscle. Invest. Ophthalmol. Vis. Sci., 36, 16451657.